NCT05624996 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT05611879 Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC Status RECRUITING Phase PHASE2
NCT05605535 Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05599984 Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05596890 Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients Status UNKNOWN Phase PHASE2
NCT05595460 Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy Status RECRUITING Phase PHASE2
NCT05580887 Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients Status UNKNOWN Phase N/A
NCT05579366 Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) Status RECRUITING Phase PHASE1/PHASE2
NCT05577702 Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT05563558 Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) Status RECRUITING Phase PHASE2
NCT05555732 Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05552651 Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT05544136 A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT05543629 A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT05535166 Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma Status RECRUITING Phase PHASE2
NCT05533775 A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT05507606 Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations Status UNKNOWN Phase PHASE2
NCT05504291 A Study to Give Treatment Inside the Eye to Treat Retinoblastoma Status RECRUITING Phase PHASE2
NCT05504278 Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation Status RECRUITING Phase PHASE1